• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-9:从功能到癌症治疗潜力

miR-9: From function to therapeutic potential in cancer.

作者信息

Khafaei Mostafa, Rezaie Ehsan, Mohammadi Ali, Shahnazi Gerdehsang Payam, Ghavidel Sara, Kadkhoda Sepideh, Zorrieh Zahra Atieh, Forouzanfar Narjes, Arabameri Hossein, Tavallaie Mahmood

机构信息

Human Genetics Research Center, Baqiyatallah Medical Science University, Tehran, Iran.

Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Science, Tehran, Iran.

出版信息

J Cell Physiol. 2019 Sep;234(9):14651-14665. doi: 10.1002/jcp.28210. Epub 2019 Jan 28.

DOI:10.1002/jcp.28210
PMID:30693512
Abstract

Malignant neoplasms are regarded as the main cause of death around the world; hence, many research studies were conducted to further perceive molecular mechanisms, treatment, and cancer prognosis. Cancer is known as a major factor for health-related problems in the world. The main challenges associated with these diseases are prompt diagnosis, disease remission classification and treatment status forecast. Therefore, progressing in such areas by developing new and optimized methods with the help of minimally invasive biological markers such as circular microRNAs (miRNAs) can be considered important. miRNA interactions with target genes have specified their role in development, apoptosis, differentiation, and proliferation and also, confirm direct miRNA function in cancer. Different miRNAs expression levels in various types of malignant neoplasms have been observed to be associated with prognosis of various carcinomas. miR-9 seems to implement opposite practices in different tissues or under various cancer incidences by influencing different genes. Aberrant miR-9 levels have been observed in many cancer types. Therefore, we intended to investigate the precise role of miR-9 in patients with malignant neoplasms. To this end, in this study, we attempted to examine different studies to clarify the overall role of miR-9 as a prognostic marker in several human tumors. The presented data in this study can help us to find the novel therapeutic avenues for treatment of human cancers.

摘要

恶性肿瘤被认为是全球主要的死亡原因;因此,人们开展了许多研究以进一步了解其分子机制、治疗方法和癌症预后。癌症是全球与健康相关问题的主要因素。与这些疾病相关的主要挑战是快速诊断、疾病缓解分类和治疗状态预测。因此,借助环状微小RNA(miRNA)等微创生物标志物开发新的优化方法,在这些领域取得进展可被视为至关重要。miRNA与靶基因的相互作用已明确其在发育、凋亡、分化和增殖中的作用,也证实了miRNA在癌症中的直接功能。在各种类型的恶性肿瘤中,不同miRNA的表达水平已被观察到与各种癌症的预后相关。miR-9似乎通过影响不同基因,在不同组织或不同癌症发生情况下发挥相反的作用。在许多癌症类型中都观察到miR-9水平异常。因此,我们旨在研究miR-9在恶性肿瘤患者中的精确作用。为此,在本研究中,我们试图审视不同的研究,以阐明miR-9作为几种人类肿瘤预后标志物的整体作用。本研究中呈现的数据可帮助我们找到治疗人类癌症的新治疗途径。

相似文献

1
miR-9: From function to therapeutic potential in cancer.微小RNA-9:从功能到癌症治疗潜力
J Cell Physiol. 2019 Sep;234(9):14651-14665. doi: 10.1002/jcp.28210. Epub 2019 Jan 28.
2
Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.对微小RNA调控的蛋白质相互作用网络的综合分析揭示了微小RNA - 149通过靶向AKT - mTOR途径在人类肝细胞癌中的肿瘤抑制作用。
Mol Cancer. 2014 Nov 26;13:253. doi: 10.1186/1476-4598-13-253.
3
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
4
Involvement of MicroRNA in T-Cell Differentiation and Malignancy.微小RNA在T细胞分化与恶性肿瘤中的作用
Int J Hematol Oncol Stem Cell Res. 2015 Jan 1;9(1):33-49.
5
Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.整合数据挖掘和荟萃分析探讨 microRNA-200 家族在各种人类恶性肿瘤中的预后作用:对异质性的考虑。
Gene. 2019 Oct 20;716:144025. doi: 10.1016/j.gene.2019.144025. Epub 2019 Aug 5.
6
MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.miRNA-296-5p 通过靶向 Bcl2 相关卵巢杀伤因子促进细胞侵袭和耐药性,导致胰腺癌预后不良。
Digestion. 2020;101(6):794-806. doi: 10.1159/000503225. Epub 2019 Sep 27.
7
Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis.微小RNA-19a在癌症诊断及预后不良中的作用
Int J Mol Sci. 2021 Apr 29;22(9):4697. doi: 10.3390/ijms22094697.
8
ChrXq27.3 miRNA cluster functions in cancer development.ChrXq27.3 微小 RNA 簇在癌症发生发展中发挥作用。
J Exp Clin Cancer Res. 2021 Mar 25;40(1):112. doi: 10.1186/s13046-021-01910-0.
9
Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.mRNA 和 miRNA 谱的综合分析揭示了 miR-193 和 miR-210 作为不同乳腺癌分子亚型潜在调控生物标志物的作用。
BMC Cancer. 2021 Jan 18;21(1):76. doi: 10.1186/s12885-020-07731-2.
10
Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications.微小 RNA-9 的新兴分子功能:癌症病理学和治疗意义。
Anticancer Agents Med Chem. 2021;21(17):2304-2314. doi: 10.2174/1871520621666210217094839.

引用本文的文献

1
The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer.血浆MiR-9和MiR-106a水平与胃癌患者腹膜癌转移的发生有关。
BMC Cancer. 2025 Jul 1;25(1):1090. doi: 10.1186/s12885-025-14427-y.
2
Long noncoding RNA MEG3 regulates cell proliferation and apoptosis by disrupting microRNA-9-5p-mediated inhibition of NDRG1 in prostate cancer.长链非编码RNA MEG3通过破坏微小RNA-9-5p介导的对前列腺癌中NDRG1的抑制作用来调节细胞增殖和凋亡。
Aging (Albany NY). 2024 Jan 24;16(2):1938-1951. doi: 10.18632/aging.205472.
3
miR-9 utilizes precursor pathways in adaptation to alcohol in mouse striatal neurons.
微小RNA-9在小鼠纹状体神经元中利用前体途径来适应酒精。
Adv Drug Alcohol Res. 2023;3. doi: 10.3389/adar.2023.11323. Epub 2023 Jun 6.
4
miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets.根据世界卫生组织胶质瘤分类的微小RNA及相关遗传生物标志物:从诊断到未来的治疗靶点
Noncoding RNA Res. 2023 Oct 7;9(1):141-152. doi: 10.1016/j.ncrna.2023.10.003. eCollection 2024 Mar.
5
MicroRNA 9 Is a Regulator of Endothelial to Mesenchymal Transition in Diabetic Retinopathy.微小 RNA9 是糖尿病视网膜病变中内皮到间充质转化的调节因子。
Invest Ophthalmol Vis Sci. 2023 Jun 1;64(7):13. doi: 10.1167/iovs.64.7.13.
6
Study of MicroRNA (miR-221-3p, miR-133a-3p, and miR-9-5p) Expressions in Oral Submucous Fibrosis and Squamous Cell Carcinoma.微小RNA(miR-221-3p、miR-133a-3p和miR-9-5p)在口腔黏膜下纤维化和鳞状细胞癌中的表达研究
Indian J Clin Biochem. 2023 Jan;38(1):73-82. doi: 10.1007/s12291-022-01035-x. Epub 2022 Apr 29.
7
MicroRNAs in T Cell-Immunotherapy.微小 RNA 与 T 细胞免疫治疗。
Int J Mol Sci. 2022 Dec 23;24(1):250. doi: 10.3390/ijms24010250.
8
miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells.miR-9 和 miR-181a 通过靶向 Gab2 抑制肝癌 HepG2 细胞的增殖和迁移。
Genes (Basel). 2022 Nov 18;13(11):2152. doi: 10.3390/genes13112152.
9
The role of microRNAs in neurodegenerative diseases: a review.微小 RNA 在神经退行性疾病中的作用:综述。
Cell Biol Toxicol. 2023 Feb;39(1):53-83. doi: 10.1007/s10565-022-09761-x. Epub 2022 Sep 20.
10
miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma.微小RNA作为滑膜肉瘤的生物标志物及可能的治疗策略
Front Pharmacol. 2022 Aug 8;13:881007. doi: 10.3389/fphar.2022.881007. eCollection 2022.